Literature DB >> 21330300

Functional characterization of the AFF (AF4/FMR2) family of RNA-binding proteins: insights into the molecular pathology of FRAXE intellectual disability.

Mireille Melko1, Dominique Douguet, Mounia Bensaid, Samantha Zongaro, Céline Verheggen, Jozef Gecz, Barbara Bardoni.   

Abstract

The AFF (AF4/FMR2) family of genes includes four members: AFF1/AF4, AFF2/FMR2, AFF3/LAF4 and AFF4/AF5q31. AFF2/FMR2 is silenced in FRAXE intellectual disability, while the other three members have been reported to form fusion genes as a consequence of chromosome translocations with the myeloid/lymphoid or mixed lineage leukemia (MLL) gene in acute lymphoblastic leukemias (ALLs). All AFF proteins are localized in the nucleus and their role as transcriptional activators with a positive action on RNA elongation was primarily studied. We have recently shown that AFF2/FMR2 localizes to nuclear speckles, subnuclear structures considered as storage/modification sites of pre-mRNA splicing factors, and modulates alternative splicing via the interaction with the G-quadruplex RNA-forming structure. We show here that similarly to AFF2/FMR2, AFF3/LAF4 and AFF4/AF5q31 localize to nuclear speckles and are able to bind RNA, having a high apparent affinity for the G-quadruplex structure. Interestingly, AFF3/LAF4 and AFF4/AF5q31, like AFF2/FMR2, modulate, in vivo, the splicing efficiency of a mini-gene containing a G-quadruplex structure in one alternatively spliced exon. Furthermore, we observed that the overexpression of AFF2/3/4 interferes with the organization and/or biogenesis of nuclear speckles. These findings fit well with our observation that enlarged nuclear speckles are present in FRAXE fibroblasts. Furthermore, our findings suggest functional redundancy among the AFF family members in the regulation of splicing and transcription. It is possible that other members of the AFF family compensate for the loss of AFF2/FMR2 activity and as such explain the relatively mild to borderline phenotype observed in FRAXE patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21330300     DOI: 10.1093/hmg/ddr069

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  31 in total

1.  AUF-1 and YB-1 independently regulate β-globin mRNA in developing erythroid cells through interactions with poly(A)-binding protein.

Authors:  Sebastiaan van Zalen; Alyssa A Lombardi; Grace R Jeschke; Elizabeth O Hexner; J Eric Russell
Journal:  Mech Dev       Date:  2015-02-23       Impact factor: 1.882

2.  Structure of the super-elongation complex subunit AFF4 C-terminal homology domain reveals requirements for AFF homo- and heterodimerization.

Authors:  Ying Chen; Patrick Cramer
Journal:  J Biol Chem       Date:  2019-05-30       Impact factor: 5.157

3.  Variants in the degron of AFF3 are associated with intellectual disability, mesomelic dysplasia, horseshoe kidney, and epileptic encephalopathy.

Authors:  Norine Voisin; Rhonda E Schnur; Sofia Douzgou; Susan M Hiatt; Cecilie F Rustad; Natasha J Brown; Dawn L Earl; Boris Keren; Olga Levchenko; Sinje Geuer; Sarah Verheyen; Diana Johnson; Yuri A Zarate; Miroslava Hančárová; David J Amor; E Martina Bebin; Jasmin Blatterer; Alfredo Brusco; Gerarda Cappuccio; Joel Charrow; Nicolas Chatron; Gregory M Cooper; Thomas Courtin; Elena Dadali; Julien Delafontaine; Ennio Del Giudice; Martine Doco; Ganka Douglas; Astrid Eisenkölbl; Tara Funari; Giuliana Giannuzzi; Ursula Gruber-Sedlmayr; Nicolas Guex; Delphine Heron; Øystein L Holla; Anna C E Hurst; Jane Juusola; David Kronn; Alexander Lavrov; Crystle Lee; Séverine Lorrain; Else Merckoll; Anna Mikhaleva; Jennifer Norman; Sylvain Pradervand; Darina Prchalová; Lindsay Rhodes; Victoria R Sanders; Zdeněk Sedláček; Heidelis A Seebacher; Elizabeth A Sellars; Fabio Sirchia; Toshiki Takenouchi; Akemi J Tanaka; Heidi Taska-Tench; Elin Tønne; Kristian Tveten; Giuseppina Vitiello; Markéta Vlčková; Tomoko Uehara; Caroline Nava; Binnaz Yalcin; Kenjiro Kosaki; Dian Donnai; Stefan Mundlos; Nicola Brunetti-Pierri; Wendy K Chung; Alexandre Reymond
Journal:  Am J Hum Genet       Date:  2021-05-06       Impact factor: 11.025

4.  Immunogenetics of Lupus Erythematosus.

Authors:  Begüm Ünlü; Ümit Türsen; Navid Jabalameli; Fahimeh Abdollahimajd; Fateme Rajabi
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

5.  Unclassified Neuroendocrine Tumor with a Novel CHD4::AFF2 Fusion: Expanding the Family of AFF2-Rearranged Head and Neck Malignancies.

Authors:  Daniel L Miller; Doreen N Palsgrove; Anu Rijal; Vivan Hathuc; Rebecca Chernock; Jeffrey Gagan; Justin A Bishop
Journal:  Head Neck Pathol       Date:  2022-02-26

6.  Autism spectrum disorder: FRAXE mutation, a rare etiology.

Authors:  F Correia; C Café; J Almeida; S Mouga; G Oliveira
Journal:  J Autism Dev Disord       Date:  2015-03

Review 7.  RNA G-Quadruplexes in Biology: Principles and Molecular Mechanisms.

Authors:  Marta M Fay; Shawn M Lyons; Pavel Ivanov
Journal:  J Mol Biol       Date:  2017-05-26       Impact factor: 5.469

8.  Development and validation in 500 female samples of a TP-PCR assay to identify AFF2 GCC expansions.

Authors:  Cecília Silva; Nuno Maia; Flávia Santos; Bárbara Rodrigues; Isabel Marques; Rosário Santos; Paula Jorge
Journal:  Sci Rep       Date:  2021-07-19       Impact factor: 4.379

9.  New susceptibility loci associated with kidney disease in type 1 diabetes.

Authors:  Niina Sandholm; Rany M Salem; Amy Jayne McKnight; Eoin P Brennan; Carol Forsblom; Tamara Isakova; Gareth J McKay; Winfred W Williams; Denise M Sadlier; Ville-Petteri Mäkinen; Elizabeth J Swan; Cameron Palmer; Andrew P Boright; Emma Ahlqvist; Harshal A Deshmukh; Benjamin J Keller; Huateng Huang; Aila J Ahola; Emma Fagerholm; Daniel Gordin; Valma Harjutsalo; Bing He; Outi Heikkilä; Kustaa Hietala; Janne Kytö; Päivi Lahermo; Markku Lehto; Raija Lithovius; Anne-May Osterholm; Maija Parkkonen; Janne Pitkäniemi; Milla Rosengård-Bärlund; Markku Saraheimo; Cinzia Sarti; Jenny Söderlund; Aino Soro-Paavonen; Anna Syreeni; Lena M Thorn; Heikki Tikkanen; Nina Tolonen; Karl Tryggvason; Jaakko Tuomilehto; Johan Wadén; Geoffrey V Gill; Sarah Prior; Candace Guiducci; Daniel B Mirel; Andrew Taylor; S Mohsen Hosseini; Hans-Henrik Parving; Peter Rossing; Lise Tarnow; Claes Ladenvall; François Alhenc-Gelas; Pierre Lefebvre; Vincent Rigalleau; Ronan Roussel; David-Alexandre Tregouet; Anna Maestroni; Silvia Maestroni; Henrik Falhammar; Tianwei Gu; Anna Möllsten; Danut Cimponeriu; Mihai Ioana; Maria Mota; Eugen Mota; Cristian Serafinceanu; Monica Stavarachi; Robert L Hanson; Robert G Nelson; Matthias Kretzler; Helen M Colhoun; Nicolae Mircea Panduru; Harvest F Gu; Kerstin Brismar; Gianpaolo Zerbini; Samy Hadjadj; Michel Marre; Leif Groop; Maria Lajer; Shelley B Bull; Daryl Waggott; Andrew D Paterson; David A Savage; Stephen C Bain; Finian Martin; Joel N Hirschhorn; Catherine Godson; Jose C Florez; Per-Henrik Groop; Alexander P Maxwell
Journal:  PLoS Genet       Date:  2012-09-20       Impact factor: 5.917

10.  Combined transcriptome studies identify AFF3 as a mediator of the oncogenic effects of β-catenin in adrenocortical carcinoma.

Authors:  L Lefèvre; H Omeiri; L Drougat; C Hantel; M Giraud; P Val; S Rodriguez; K Perlemoine; C Blugeon; F Beuschlein; A de Reyniès; M Rizk-Rabin; J Bertherat; B Ragazzon
Journal:  Oncogenesis       Date:  2015-07-27       Impact factor: 7.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.